TELA Bio Profit Margin

TELA Bio (TELA) currently reports a profit margin of -49.3% as of March 2026. That compares with -61.0% in the prior-year period — up 19.2% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore TELA Bio's profit margin history and peer comparisons.

TELA Bio's profit margin increased from -61.0% to -49.3% — a 19.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TELA Bio's profit margin of -49.3% is lower than the Healthcare sector average of 14.34%. That is roughly 443.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but TELA Bio's current -49.3% should be judged against Healthcare norms (sector average: 14.34%) and against TELA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -49.3%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for TELA Bio, and consider following TELA for alerts when major investors trade the stock.